| Letermovir Use in Heart Transplant Recipients (NCT04904614) | Tufts Medical Center | 2022-01-05 |
| A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders (NCT04154488) | X4 Pharmaceuticals | 2021-10-16 |
| Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies (NCT04710212) | Duke University | 2021-03-12 |
| PC001- A Study to Evaluate the Usability of PointCheck (NCT04448301) | Leuko Labs, Inc. | 2021-02-09 |
| Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients (NCT05221593) | Al-Azhar University | 2020-08-01 |
| Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer (NCT04187898) | Spectrum Pharmaceuticals, Inc | 2020-03-11 |
| Late Neutropenia in VLBW Preterm Babies (NCT04217811) | Hillel Yaffe Medical Center | 2020-01-01 |
| AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients (NCT05793073) | Centre Hospitalier Universitaire de Nice | 2019-10-01 |
| Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) (NCT05585463) | Fundació Sant Joan de Déu | 2019-09-01 |
| Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer (NCT04009941) | Peking University | 2019-08-01 |
| A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors (NCT03798665) | Affiliated Hospital of North Sichuan Medical College | 2018-07-06 |
| Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients (NCT03530072) | Karius, Inc. | 2018-05-07 |
| Study to Compare the Efficacy and Safety of F-627 and GRAN® (NCT04174599) | EVIVE Biotechnology | 2018-04-12 |
| Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT03252431) | EVIVE Biotechnology | 2018-04-12 |
| Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF) (NCT03498248) | DERSHENG SUN | 2018-02-19 |
| Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer (NCT05283616) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2017-05-15 |
| SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide (NCT02953340) | Spectrum Pharmaceuticals, Inc | 2017-05-10 |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia (NCT03019939) | M.D. Anderson Cancer Center | 2017-03-28 |
| Profiling Neutrophil Counts in Patients on Chemotherapy (NCT02806557) | University of Leeds | 2016-09-01 |
| Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02872103) | EVIVE Biotechnology | 2016-08-01 |
| Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay (NCT02912117) | Karius, Inc. | 2016-08-01 |
| SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia (NCT02324231) | Swiss Pediatric Oncology Group | 2016-04-01 |
| Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients (NCT02967341) | Universitair Ziekenhuis Brussel | 2016-03-01 |
| Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) (NCT02685111) | Asan Medical Center | 2016-02-01 |
| SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) (NCT02643420) | Spectrum Pharmaceuticals, Inc | 2016-01-19 |
| Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg (NCT02621905) | Mayne Pharma International Pty Ltd | 2015-11-01 |
| Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations (NCT02589301) | Eurofarma Laboratorios S.A. | 2015-11-01 |
| Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) (NCT02452034) | Merck Sharp & Dohme LLC | 2015-09-07 |
| A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants (NCT02629289) | Pfizer | 2015-08-01 |
| Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy (NCT02679443) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2015-07-01 |
| Home Away From Home - Medical Outcomes (NCT02774850) | Children's Hospital of Philadelphia | 2015-06-01 |
| A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement (NCT02190721) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-05-12 |
| Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% (NCT02414581) | Hospital Regional de Alta Especialidad del Bajio | 2015-04-01 |
| Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia (NCT02282215) | Cellerant Therapeutics | 2014-12-01 |
| Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome (NCT02231879) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-14 |
| Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma (NCT02238873) | Rabin Medical Center | 2014-10-01 |
| Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis (NCT01916057) | Assistance Publique - Hôpitaux de Paris | 2013-11-19 |
| LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy (NCT04562922) | VitalMel | 2013-11-11 |
| A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. (NCT02135887) | Microbio Co Ltd | 2013-11-04 |
| Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia (NCT01918241) | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | 2013-07-01 |
| Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer (NCT01724866) | Spectrum Pharmaceuticals, Inc | 2013-03-25 |
| Effect of Body Mass on Filgrastim Pharmacokinetics (NCT01719432) | Aaron Cumpston, PharmD, BCOP | 2012-12-05 |
| Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02527746) | EVIVE Biotechnology | 2012-12-01 |
| Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia (NCT01714570) | Chinese PLA General Hospital | 2012-11-01 |
| Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation (NCT01714557) | Chinese PLA General Hospital | 2012-09-01 |
| Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant (NCT01660347) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-08-01 |
| Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT01629082) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-06-06 |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT01648322) | EVIVE Biotechnology | 2012-06-01 |
| A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy (NCT01560195) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy (NCT01571518) | Hyuk moon Kim | 2012-04-01 |
| A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy (NCT01611051) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients (NCT01637493) | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | 2012-02-01 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326) | Daniel Benjamin | 2011-11-01 |
| Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (NCT01371656) | Children's Oncology Group | 2011-09-01 |
| Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (NCT01417169) | Seoul National University Hospital | 2011-08-01 |
| Decitabine for High-Risk Sickle Cell Disease (NCT01375608) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-06-01 |
| A Study of Empirical Antifungal Therapy With Itraconazole (NCT01706562) | Janssen Korea, Ltd., Korea | 2011-05-01 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (NCT01484015) | Wake Forest University Health Sciences | 2011-02-01 |
| A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy (NCT02119715) | Jiangsu HengRui Medicine Co., Ltd. | 2011-02-01 |
| AMD 3100 for Treatment of Myelokathexis (NCT01058993) | University of Washington | 2010-10-01 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia (NCT01187017) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia (NCT01193283) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients (NCT02544685) | S&D Pharma SK s.r.o. | 2010-07-01 |
| Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients (NCT01114165) | University Hospital Muenster | 2010-05-01 |
| Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation (NCT01135589) | Asan Medical Center | 2010-04-01 |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy (NCT01164215) | UNC Lineberger Comprehensive Cancer Center | 2010-02-01 |
| A Phase I Study of Mozobil in the Treatment of Patients With WHIMS (NCT00967785) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-06 |
| PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study (NCT00911170) | Amgen | 2009-11-03 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System (NCT00806351) | Pfizer | 2009-08-01 |
| The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants (NCT01021683) | Janssen Korea, Ltd., Korea | 2009-07-01 |
| Outpatient Neutropenic Diet Study (NCT00947648) | M.D. Anderson Cancer Center | 2009-07-01 |
| Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children. (NCT00937053) | St. Justine's Hospital | 2009-06-01 |
| Safety of Cotrimoxazole in HIV- and HAART-exposed Infants (NCT01086878) | Harvard School of Public Health (HSPH) | 2009-02-01 |
| Diagnostic and Management Strategies for Invasive Aspergillosis (NCT00816088) | King's College Hospital NHS Trust | 2008-12-01 |
| Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer (NCT00771810) | Tarix Pharmaceuticals | 2008-10-01 |
| Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients (NCT01060462) | Janssen Korea, Ltd., Korea | 2008-08-01 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (NCT00730314) | Children's Hospital Los Angeles | 2008-08-01 |
| Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations (NCT00673348) | The Catholic University of Korea | 2008-05-01 |
| Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) (NCT00627393) | Carelon Research | 2008-04-01 |
| Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia (NCT00913042) | Assistance Publique - Hôpitaux de Paris | 2008-02-01 |
| A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection (NCT00784368) | Janssen Pharmaceutical K.K. | 2008-01-01 |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) (NCT00686543) | Merck Sharp & Dohme LLC | 2007-12-01 |
| The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies (NCT01669005) | Centre Hospitalier Universitaire Vaudois | 2007-11-01 |
| A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy (NCT00555516) | Tri-Service General Hospital (TSGH) | 2007-11-01 |
| A Study of Ceftobiprole in Patients With Fever and Neutropenia. (NCT00529282) | Basilea Pharmaceutica | 2007-10-01 |
| G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy (NCT00770172) | Centre Francois Baclesse | 2007-10-01 |
| Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia (NCT00497809) | AviGenics | 2007-08-01 |
| Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia (NCT00445497) | Clatterbridge Centre for Oncology | 2007-07-01 |
| A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia (NCT00520325) | Enzon Pharmaceuticals, Inc. | 2007-06-01 |
| Daptomycin in Treating Neutropenia and Fever in Patients With Cancer (NCT00335478) | OHSU Knight Cancer Institute | 2006-12-01 |
| Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia (NCT00886496) | Enzon Pharmaceuticals, Inc. | 2006-11-01 |
| Garlic in Patients With Febrile Neutropenia (NCT00247039) | Hadassah Medical Organization | 2006-06-01 |
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer (NCT00352300) | Gynecologic Oncology Group | 2006-06-01 |
| Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients (NCT00364468) | Kyowa Kirin Co., Ltd. | 2006-03-01 |
| Fever and Neutropenia in Pediatric Oncology Patients (NCT03768869) | University of Colorado, Denver | 2006-02-01 |
| Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia (NCT00260689) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-11-28 |
| Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy (NCT00296049) | Wake Forest University Health Sciences | 2005-07-01 |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00077311) | Alliance for Clinical Trials in Oncology | 2004-08-01 |
| FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy (NCT00125723) | Amgen | 2004-05-01 |
| MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) (NCT00082537) | Merck Sharp & Dohme LLC | 2004-04-01 |